2016
DOI: 10.1186/s40249-016-0194-x
|View full text |Cite
|
Sign up to set email alerts
|

Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar

Abstract: BackgroundFollowing the decline of malaria transmission in many countries and regions, serological parameters have become particularly useful for estimating malaria transmission in low-intensity areas. This study evaluated a novel serological marker, Malaria Random Constructed Antigen-1 (M.RCAg-1), which contains 11 epitopes from eight Plasmodium falciparum antigens, as a tool for assessing malaria transmission intensity along the border area of China-Myanmar.MethodSerum from Plasmodium falciparum and P. vivax… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 47 publications
0
11
0
Order By: Relevance
“…For malaria serological studies, tailoring the sensitivity of the assay using a highly antigenic protein has previously been suggested as a method to improve serological testing and the estimates generated by this data (8). A recent assessment of a multi-epitope chimeric protein for use as a serological marker in P. falciparum elimination settings in Southeast Asia demonstrated the potential of chimeric proteins in serological studies (25). Another protein chimera based on the fusion of the P. falciparum MSP1 and MSP8 antigens has shown e cacy for the induction of growth-inhibitory antibodies in animal models (36,37), but has been yet to be assayed against human plasma from naturally-exposed populations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For malaria serological studies, tailoring the sensitivity of the assay using a highly antigenic protein has previously been suggested as a method to improve serological testing and the estimates generated by this data (8). A recent assessment of a multi-epitope chimeric protein for use as a serological marker in P. falciparum elimination settings in Southeast Asia demonstrated the potential of chimeric proteins in serological studies (25). Another protein chimera based on the fusion of the P. falciparum MSP1 and MSP8 antigens has shown e cacy for the induction of growth-inhibitory antibodies in animal models (36,37), but has been yet to be assayed against human plasma from naturally-exposed populations.…”
Section: Discussionmentioning
confidence: 99%
“…The addition of pan-malaria antigens for IgG detection could improve malaria exposure estimates to aid in malaria elimination campaigns, which aim to eliminate all malaria transmission within a region, not just an individual species. Recently, the use of designed chimeric Plasmodium proteins as serosurveillance tools has been explored, including a multi-epitope chimeric antigen that contained epitopes from eight P. falciparum antigens (25,26). While this antigen was wellrecognized by P. falciparum-infected individuals in endemic regions along the China-Myanmar border, it displayed limited cross-reactivity with P. vivax-infected individuals (25).…”
Section: Introductionmentioning
confidence: 99%
“…It is important to remember that many antigens present in the pre-erythrocyte and erythrocyte stages play important roles in the protection against malaria [3,27,28]. Several studies have been carried out on the functionality of P. falciparum antigens in diagnosis and it has been found, for example, that MRCAg1 chimeric antigen, containing eight epitopes of P. falciparum, is a potential marker for the detection of malaria caused by P. falciparum [29][30][31]. In addition, some studies have been conducted to understand the antibody response against malaria infection using ELISA [2,3], suggesting that ELISA is a good method for evaluating the humoral immune response.…”
Section: Discussionmentioning
confidence: 99%
“…vivax [ 88 ], serological signatures of hypnozoite carriage [ 92 ], and vector-specific antigenic targets in mosquito saliva [ 93 , 94 ]. The programmatic applications of serology have yet to be fully tested, though various approaches are being evaluated, including serological markers of incident infections [ 89 , 95 109 ]. Research is currently underway to identify a variety of biomarkers indicative of recent infection that are detectable for different durations following parasite infection, allowing finer-scale estimation of time since infection.…”
Section: Research Agenda For Measuring Transmissionmentioning
confidence: 99%